BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

908 related articles for article (PubMed ID: 27865390)

  • 1. Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.
    Sharpe S; White A; Sarfas C; Sibley L; Gleeson F; McIntyre A; Basaraba R; Clark S; Hall G; Rayner E; Williams A; Marsh PD; Dennis M
    Tuberculosis (Edinb); 2016 Dec; 101():174-190. PubMed ID: 27865390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques.
    White AD; Sarfas C; West K; Sibley LS; Wareham AS; Clark S; Dennis MJ; Williams A; Marsh PD; Sharpe SA
    Clin Vaccine Immunol; 2015 Sep; 22(9):992-1003. PubMed ID: 26108288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Efficacy of Inhaled BCG Vaccination Against Ultra-Low Dose Aerosol
    White AD; Sarfas C; Sibley LS; Gullick J; Clark S; Rayner E; Gleeson F; Català M; Nogueira I; Cardona PJ; Vilaplana C; Dennis MJ; Williams A; Sharpe SA
    Pharmaceutics; 2020 Apr; 12(5):. PubMed ID: 32344890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates.
    Jeyanathan M; Shao Z; Yu X; Harkness R; Jiang R; Li J; Xing Z; Zhu T
    PLoS One; 2015; 10(8):e0135009. PubMed ID: 26252520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge.
    Darrah PA; Bolton DL; Lackner AA; Kaushal D; Aye PP; Mehra S; Blanchard JL; Didier PJ; Roy CJ; Rao SS; Hokey DA; Scanga CA; Sizemore DR; Sadoff JC; Roederer M; Seder RA
    J Immunol; 2014 Aug; 193(4):1799-811. PubMed ID: 25024382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis.
    Waeckerle-Men Y; Bruffaerts N; Liang Y; Jurion F; Sander P; Kündig TM; Huygen K; Johansen P
    Vaccine; 2013 Feb; 31(7):1057-64. PubMed ID: 23273509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
    PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice.
    Nandakumar S; Kannanganat S; Posey JE; Amara RR; Sable SB
    PLoS One; 2014; 9(11):e113951. PubMed ID: 25419982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis.
    Perdomo C; Zedler U; Kühl AA; Lozza L; Saikali P; Sander LE; Vogelzang A; Kaufmann SH; Kupz A
    mBio; 2016 Nov; 7(6):. PubMed ID: 27879332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice.
    Hu Z; Wong KW; Zhao HM; Wen HL; Ji P; Ma H; Wu K; Lu SH; Li F; Li ZM; Shu T; Xu JQ; Lowrie DB; Fan XY
    Mol Ther; 2017 May; 25(5):1222-1233. PubMed ID: 28342639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
    Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
    Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable BCG efficacy in rhesus populations: Pulmonary BCG provides protection where standard intra-dermal vaccination fails.
    Verreck FAW; Tchilian EZ; Vervenne RAW; Sombroek CC; Kondova I; Eissen OA; Sommandas V; van der Werff NM; Verschoor E; Braskamp G; Bakker J; Langermans JAM; Heidt PJ; Ottenhoff THM; van Kralingen KW; Thomas AW; Beverley PCL; Kocken CHM
    Tuberculosis (Edinb); 2017 May; 104():46-57. PubMed ID: 28454649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prime-boost vaccination strategy with bacillus Calmette-Guérin (BCG) and liposomized alpha-crystalline protein 1 reinvigorates BCG potency.
    Siddiqui KF; Amir M; Khan N; Rama Krishna G; Sheikh JA; Rajagopal K; Agrewala JN
    Clin Exp Immunol; 2015 Aug; 181(2):286-96. PubMed ID: 25845290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
    Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
    PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
    Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S
    Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCR repertoire, clonal dominance, and pulmonary trafficking of mycobacterium-specific CD4+ and CD8+ T effector cells in immunity against tuberculosis.
    Du G; Chen CY; Shen Y; Qiu L; Huang D; Wang R; Chen ZW
    J Immunol; 2010 Oct; 185(7):3940-7. PubMed ID: 20805423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the Infant Immune System and the Influence and Immunogenicity of BCG Vaccination in Infant and Adult Rhesus Macaques.
    Sarfas C; White AD; Sibley L; Morrison AL; Gullick J; Lawrence S; Dennis MJ; Marsh PD; Fletcher HA; Sharpe SA
    Front Immunol; 2021; 12():754589. PubMed ID: 34707617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection.
    Zhang M; Dong C; Xiong S
    Hum Vaccin Immunother; 2017 Apr; 13(4):816-822. PubMed ID: 27960596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.